
Brad Morganstern, MD
@bradmorganstern
@NYULangoneLI Medical Director, IBD Program - Long Island Tweets are my own. RT ≠ endorsement
ID: 120481509
https://nyulangone.org/doctors/1750540449/bradley-m-morganstern 06-03-2010 15:23:13
1,1K Tweet
1,1K Followers
930 Following

Join us this Friday NYU Langone Health for the best yet Big Gut #IBD!!

Kicking off NYU Langone Health Big Gut IBD 2024! Gil Y. Melmed, MD, MS reviews 1st-line 💉💊 for UC. Some highlights: ▶️ RCTs finally assessing proctitis and urgency ▶️ small molecules continue to show rapid onset of action ▶️ NO matter what you choose from the “buffet” - monitor and T2T!


NYU Langone Health #BigGut2024 happening now! Fantastic talks by #LisaMalter & Gil Y. Melmed, MD, MS on first and second line treatments for #IBD Millie Long David Hudesman Shannon Chang, MD Jordan Axelrad, MD, MPH Sophie Balzora, MD, FACG Ariela Holmer Simon Hong



Surgery as first-line option in #IBD Shannon Chang, MD ✨ —> limited remission rates with current advanced therapies —> 🚨delaying surgery when ultimately required can lead to inc AEs Gil Y. Melmed, MD, MS Millie Long David Hudesman Sophie Balzora, MD, FACG Jordan Axelrad, MD, MPH Ariela Holmer Simon Hong


Amazing talk Sophie Balzora, MD, FACG on Social Determinants of Health in #IBD 🚨impact —> higher food insecurity, lower social support, increased hospitalization, lower used of advanced therapies- inclusion in RCTs impt to move from equality —> equity ABGH David Hudesman


Outstanding talk Ariela Holmer on transitioning from peds —> adult care in #IBD —Education is 🔑 David Hudesman Shannon Chang, MD Simon Hong Jordan Axelrad, MD, MPH Sophie Balzora, MD, FACG Brad Morganstern, MD NYU Grossman School of Medicine




Millie Long talking precision medicine at #biggutIBD NYU Langone Health. Next stop: breaking the therapeutic ceiling 🔨


Keynote lecture by Millie Long on the current status of precision 💊 in IBD NYU Langone Health #biggutibd Some 🔑: 1️⃣ Profile UK: 🚫 utility of PredictSURE, but DID show benefit of early combo 2️⃣ Can use HLA-DQ A1*05, TPMT & NUDT15 to guide TNFa/IMM 3️⃣ TL1A’s (+ companion dx) on the way!


Updates on acute severe UC by Jordan Axelrad, MD, MPH at NYU Langone Health #biggutIBD! CDI+ is a poor prognostic factor, inpatient IFX 5 mg/kg 🟰 10mg/kg, and JAKi are now an effective option (but can still use cyclo☝️)


Congratulations 2024 Emerging Leader Prize Recipient Jordan Axelrad, MD, MPH, NYU Langone Health NYU Grossman School of Medicine. Dr. Axelrad's own experience with Crohn’s disease drives his commitment to improving patient outcomes. Learn more about his work at ShermanPrize.org


In a late-breaking abstract at #ACG2024, Violeta Popov, MD PhD presented a systematic review and meta-analysis evaluating the impact of GLP-1RA on GI endoscopy and potential safety concerns linked to delayed gastric emptying.



Congrats to Jordan Axelrad, MD, MPH and amazing clinician, scientist, colleague and friend on his Sherman Prize! All of us at Gastroenterology & Hepatology | NYU Langone Health NYU Langone Health are so proud of you and honored to work with you 🙌🚀 #AIBD2024 @IBDConference

Congratulations to Jordan Axelrad, MD, MPH NYU Langone Health on receiving the Sherman Emerging Leader Prize at the 2024 AIBD conference. Your leadership, passion, excellence, scientific rigor, and compassion represent us at our best! Congratulations! #AIBD2024 #IBDConference


Welcome Michael Todd Dolinger, MD MBA to the Inflammatory Bowel Disease Center NYU Langone Health as Director of Pediatric #IBD Gastroenterology & Hepatology | NYU Langone Health NYU Department of Medicine NYU Grossman School of Medicine #crohnsdisease #ulcerativecolitis Crohn's & Colitis Foundation NASPGHAN


And….#NYU’s Big Gut course is off to a great start #DrRadio Doctor Radio Edward Barnes MD MPH Corey Siegel Tracy Hull We have an outstanding lineup tomorrow with a focus on cutting edge research and clinical pearls at the forefront of #IBD.NYU Langone Health Gastroenterology & Hepatology | NYU Langone Health


All things JAK with Jordan Axelrad, MD, MPH at Gastroenterology & Hepatology | NYU Langone Health #BigGutSeminars #IBD ✅ UPA effective for CD perianal fistula ✅ Network metas provide indirect comparative data: UPA🥇effective for both UC/CD ✅ Of the side effects - most common may be acne (“JAKne”)☝️discuss w pt!
